Biechele Royce Advisors Merck & Co., Inc. Transaction History

Biechele Royce Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 17, 2019	SELL	$69.58 - $79.36 $200,738 - $228,953	-2,885 Closed	0 $0
Q4 2018 Feb 05, 2019	SELL	$65.24 - $75.71 $15,331 - $17,791	-235 Reduced 7.53%	2,885 $220,000
Q3 2018 Oct 30, 2018	BUY	$57.69 - $67.84 $179,992 - $211,660	3,120 New	3,120 $221,000
Q1 2018 Apr 20, 2018	SELL	$50.96 - $59.23 $411,858 - $478,696	-8,082 Closed	0 $0
Q4 2017 Feb 08, 2018	BUY	$51.62 - $61.64 $417,192 - $498,174	8,082	8,082 $454,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Biechele Royce Advisors, based on Form 13F filings with the SEC.

Stay updated on Biechele Royce Advisors with notifications on news.